|
Volumn 21, Issue 4, 2003, Pages 586-587
|
How can we tell when cancer vaccines vaccinate?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
DIPHTHERIA VACCINE;
GAMMA INTERFERON;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
T LYMPHOCYTE RECEPTOR;
ANTIBODY DETECTION;
ANTIBODY RESPONSE;
ANTIGEN PRESENTING CELL;
ANTINEOPLASTIC ACTIVITY;
B LYMPHOCYTE;
CANCER RELAPSE;
CANCER SURVIVAL;
CD8+ T LYMPHOCYTE;
CELL SELECTION;
DELAYED HYPERSENSITIVITY;
EDITORIAL;
ENZYME LINKED IMMUNOSPOT ASSAY;
HUMAN;
IMMUNE FUNCTION TEST;
IMMUNE RESPONSE;
IMMUNITY;
IMMUNOGENICITY;
INFLAMMATION;
PRIORITY JOURNAL;
RABIES VIRUS;
SEROLOGY;
T LYMPHOCYTE;
VACCINATION;
IMMUNOLOGY;
NEOPLASM;
NOTE;
CANCER VACCINES;
HUMANS;
NEOPLASMS;
T-LYMPHOCYTES;
|
EID: 0037441817
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2003.12.065 Document Type: Editorial |
Times cited : (8)
|
References (5)
|